Sosei Heptares Wins Licensing Deal of the Year and Executive of the Year at the Inaugural Informa Pharma Intelligence Awards Japan
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 10 - Sosei Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sosei Group Today - Breaking & Trending Today
Sosei Heptares' Oral, Selective M4 Receptor Agonist
Neurocrine to conduct placebo-controlled Phase 2 study to investigate NBI-1117568 (formerly HTL-0016878) as a potential new treatment for schizophrenia...
Source: globenewswire.com
Sosei Heptares and AbbVie Enter New Multi-target
New strategic collaboration leverages Sosei Heptares’ StaR® technology and SBDD platform and AbbVie’s extensive neuroscience expertise Second collaboration...
Source: globenewswire.com
Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Cancer Research UK and Sosei Heptares sign agreement to
HTL0039732 is a novel EP4 antagonist with potential to treat a wide range of cancers in combination with other immunotherapies...
Source: globenewswire.com